Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 03 - 11 save search
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
Published: 2021-03-11 (Crawled : 23:03) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.82%
H: 4.76%
C: -0.81%
financial results results program
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Published: 2021-03-11 (Crawled : 23:03) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.33%
H: 5.26%
C: 2.63%
AGE A | $11.1 0.0% 3.8K
|
Health Technology
|
| O: 0.0%
H: 0.47%
C: -5.58%
financial results results
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
Published: 2021-03-11 (Crawled : 23:00) - globenewswire.com
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: -0.24%
H: 9.37%
C: -1.18%
Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Published: 2021-03-11 (Crawled : 22:01) - biospace.com/
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: 1.64%
H: 2.09%
C: 1.61%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.33%
H: 5.26%
C: 2.63%
financial results results
Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
Published: 2021-03-11 (Crawled : 22:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -6.02%
H: 12.99%
C: 4.52%
financial results results
Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update
Published: 2021-03-11 (Crawled : 22:00) - globenewswire.com
SPRO | $1.41 -4.08% -4.26% 380K
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: -5.16%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -4.4%
H: 4.6%
C: -2.09%
results
Nabriva Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Updates
Published: 2021-03-11 (Crawled : 22:00) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: -5.3%
H: 2.71%
C: 1.56%
financial results results
Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Published: 2021-03-11 (Crawled : 22:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 0.0%
H: 2.39%
C: 0.8%
offering therapeutics publication
Harpoon Therapeutics Announces Poster Presentations and Publication of Abstracts for AACR Annual Meeting 2021
Published: 2021-03-11 (Crawled : 19:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 0.05%
H: 1.22%
C: -0.91%
Anika to Participate in the Sidoti Spring Virtual Investor Conference
Published: 2021-03-11 (Crawled : 18:00) - globenewswire.com
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
|
| O: 0.66%
H: 5.01%
C: 3.26%
conference
ImmunityBio Announces Novel ACE2 Decoy COVID-19 Therapeutic that Shows High Binding to SARS-CoV-2 Variants and Neutralizes Live Viruses
Published: 2021-03-11 (Crawled : 17:02) - biospace.com/
IBRX | $5.265 7.23% 6.74% 4.6M
|
Manufacturing
|
| O: 5.51%
H: 0.0%
C: -16.66%
covid sars-cov-2
Biopharma Companies Take Aim at Spinal Cord Injuries
Published: 2021-03-11 (Crawled : 16:01) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.33%
H: 5.26%
C: 2.63%
biopharma spinal cord
Atossa Therapeutics Announces Receipt of FDA Safe to Proceed Letter for Treatment of an Ovarian Cancer Patient with Oral Endoxifen Under Expanded Access Pathway
Published: 2021-03-11 (Crawled : 15:00) - globenewswire.com
ATOS | $1.37 -3.52% -3.65% 1.2M
|
Health Technology
|
| O: -0.34%
H: 24.14%
C: 11.03%
treatment fda cancer ovarian cancer
Hoth Therapeutics Executes Agreement to Assess the Effect of HT-003 Therapeutic Platform on Ulcerative Colitis and Crohn's Disease
Published: 2021-03-11 (Crawled : 14:31) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 12.11%
H: 0.94%
C: -3.76%
disease ulcerative colitis
Akebia Therapeutics Celebrates World Kidney Day and National Kidney Month
Published: 2021-03-11 (Crawled : 14:19) - biospace.com/
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 2.27%
H: 4.17%
C: 3.33%
therapeutics kidney
Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors
Published: 2021-03-11 (Crawled : 14:18) - biospace.com/
MRSN | $3.255 -2.55% -2.61% 2.4M
|
Health Technology
|
| O: 2.98%
H: 3.38%
C: 1.91%
Tvardi Therapeutics Appoints Michael Wyzga, Former CFO of Genzyme, to Board of Directors
Published: 2021-03-11 (Crawled : 14:02) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
Viracta Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference
Published: 2021-03-11 (Crawled : 14:02) - biospace.com/
VIRX | $0.88 -3.19% -3.3% 53K
|
Manufacturing
|
| O: 0.11%
H: 8.81%
C: 7.62%
CymaBay Therapeutics to Present at the 2021 NASH-TAG Conference
Published: 2021-03-11 (Crawled : 14:02) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 1.22%
H: 4.23%
C: 4.23%
conference nash presentation therapeutics
AavantiBio Bolsters Leadership Team with Appointment of Ty Howton as Chief Operating Officer and General Counsel
Published: 2021-03-11 (Crawled : 14:01) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.2%
H: 1.38%
C: 0.2%
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: 0.21%
H: 3.44%
C: 2.93%
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: 3.61%
H: 3.49%
C: 3.49%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.